Bhagwat SV, Mur C, Vandekopple M, Zhao B, et al. Imlunestrant is an Oral, Brain-Penetrant Selective Estrogen Receptor Degrader with Potent Antitumor Activity in ESR1 Wildtype and Mutant Breast Cancer. Cancer Res 2024 Dec 9. doi: 10.1158/0008-5472.CAN-24-2608.
PMID: 39652577